Abstract
The relationship between obesity and type 2 diabetes has been known for decades and the recent important increase in such diseases represents a major medical problem worldwide. Several prospective studies present both impaired insulin release and insulin resistance as the major factors for the development of type 2 diabetes. The factor that dominates in obesity is the permanent elevation of plasma FFA and the predominant utilization of lipids by the muscle inducing a diminution of glucose uptake and, therefore, insulin resistance. The rise in insulin secretion appears to be a compensatory mechanism that responds to the increased levels of circulating glucose. The fall in insulin secretion occurs as a late phenomenon. The present review aims at analysing the mechanisms that lead human obesity to type 2 diabetes and using the pathophysiological information for the prevention of diabetes. The partial reversibility of the evolution of obesity towards diabetes is well demonstrated today by lifestyle changes and multidisciplinary weight loss programs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Felber, JP., Golay, A. Pathways from obesity to diabetes. Int J Obes 26 (Suppl 2), S39–S45 (2002). https://doi.org/10.1038/sj.ijo.0802126
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802126
Keywords
This article is cited by
-
Improving Fairness and Equity by Minimizing Community Vulnerability to Food Accessibility: A Computational Urbanism Approach
Social Indicators Research (2024)
-
Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
Current Diabetes Reports (2023)
-
Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review
Drugs & Aging (2023)
-
Immunohistochemical identification and assessment of the location of leptin, visfatin and chemerin in the liver of men with different body mass index
BMC Gastroenterology (2022)
-
The correlation between serum inflammatory, antioxidant, glucose handling biomarkers, and Dietary Antioxidant Index (DAI) and the role of DAI in obesity/overweight causation: population-based case–control study
International Journal of Obesity (2021)